Halozyme Q4 2025 Earnings Surge: Royalty Revenue Soars 52%
Halozyme Therapeutics Inc. (NASDAQ: HALO) hit record revenue. Full-year 2025 revenue reached $1.4 billion. So this is 38% growth year-over-year. ...
Halozyme Therapeutics Inc. (NASDAQ: HALO) hit record revenue. Full-year 2025 revenue reached $1.4 billion. So this is 38% growth year-over-year. ...
Executive Summary Constellation Energy Corporation has emerged as one of the most strategically important power producers in the United States, ...
Shares of Ingersoll Rand Inc. (IR) rose 4.56% to $98.51 in midday trading Friday after the industrial equipment manufacturer reported ...
Marcus & Millichap (NYSE: MMI) MMI Q4 2025 Earnings exceeded expectations as the real estate investment services firm reported revenue growth. ...
Sensient Technologies Corporation (NYSE: SXT) The company reported revenue of $393.4 million in the fourth quarter of 2025. Sensient Q4 ...
Follow us on Google for the latest stock newsFollow Seeking Alpha on Google for the latest stock newsEarnings Call Insights: ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.